CEO Søren Bregenholt presents at the Redeye Fight Cancer Day 2023.
Click here for a link to the presentation.
LATEST NEWS
Alligator Bioscience to Participate in Upcoming Scientific and Industry Conferences in January and February 2023
Lund, Sweden – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that senior company representatives will participate in the fo …
Alligator Bioscience Announces Positive Interim Results from Mitazalimab OPTIMIZE-1 Phase 2 Trial in Pancreatic Cancer Exceeding 50% Objective Response Rate
52% Objective Response Rate in pre-planned interim efficacy analysis of mitazalimab combined with mFOLFIRINOX in 1st line metastatic pancrea …
Alligator Bioscience and Orion Corporation announce the initiation of the second program of their Immuno-oncology Research Collaboration and License Agreement
The second project aims to develop a bispecific antibody with potential applications in solid tumors Alligator and Orion each to provide val …